Decoding thrombosis: A closer look

Written by: Dr Karen Breen
Published:
Edited by: Kate Forristal

Thrombosis, a complex and often enigmatic medical phenomenon, has captivated the attention of researchers and healthcare professionals alike. The intricate interplay of cellular and molecular mechanisms leading to the formation of blood clots poses challenges and opportunities for understanding, prevention, and treatment. In her latest online article, Dr Karen Breen delves into the fascinating world of thrombosis, unravelling its mysteries and shedding light on the latest developments in research and clinical practices.

The basics of thrombosis:

Thrombosis is a condition characterised by the abnormal formation of blood clots within blood vessels. While the body's ability to form clots is a crucial aspect of wound healing and preventing excessive bleeding, the balance can be disrupted, leading to harmful consequences. Thrombosis can occur in arteries or veins, with each presenting its unique set of challenges.

 

Understanding the culprits:

A key player in thrombosis is platelets, small blood cells that play a vital role in clotting. When blood vessels are injured, platelets rush to the site to form a plug and prevent excessive bleeding. However, in the case of thrombosis, this process becomes dysregulated, leading to the formation of clots within healthy blood vessels. Factors such as genetics, lifestyle, and underlying medical conditions can contribute to this imbalance.

 

Types of thrombosis:

Thrombosis manifests in various forms, each with its own set of clinical implications. Arterial thrombosis occurs in arteries and is often associated with conditions like atherosclerosis, where fatty deposits build up in the arterial walls. Venous thrombosis, on the other hand, occurs in veins and can lead to serious complications like deep vein thrombosis (DVT) or pulmonary embolism.

 

The silent threat:

One of the challenges posed by thrombosis is its ability to strike silently, often without noticeable symptoms until complications arise. This silent threat underscores the importance of preventive measures, especially for individuals with risk factors such as a family history of clotting disorders, sedentary lifestyle, or certain chronic diseases.

 

Innovations in diagnosis and treatment:

Advancements in medical technology have significantly improved the diagnosis and treatment of thrombosis. Non-invasive imaging techniques, such as ultrasound and magnetic resonance imaging (MRI), allow for the detection of blood clots with greater precision. Anticoagulant medications, such as heparin and warfarin, have long been the mainstays of treatment, but newer oral anticoagulants offer more targeted options with fewer side effects.

 

Preventing thrombosis:

Prevention is a crucial aspect of managing thrombosis. Lifestyle modifications, including regular exercise, a balanced diet, and avoiding tobacco use, can contribute to a healthy circulatory system. Additionally, understanding and managing risk factors, especially in high-risk individuals, play a pivotal role in preventing thrombotic events.

 

Dr Karen Breen is an esteemed haematologist with over 20 years of experience. You can schedule an appointment with Dr Breen on her Top Doctors profile.

By Dr Karen Breen
Haematology

Dr Karen Breen is an experienced and renowned consultant haematologist practising at her private clinics in London. Her specialties include thrombosis, obstetric haematology, and clotting, bleeding, and platelet disorders. Currently, Dr Breen is practising at Guys' Hospital, a private healthcare clinic of Guys' and St Thomas' NHS Trust, in addition to London Bridge Hospital.

Dr Breen completed her basic medical training whilst in Ireland, achieving her MB BCh in 2000. She later received her membership with the Royal College of Physicians of Ireland before eventually receiving her fellowship with the Royal College of Pathology. Dr Breen received her postgraduate haematology speciality training mostly in Ireland. She later relocated to London to complete research on antiphospholipid syndrome which led to her receiving an MD in 2015.

Over the years, Dr Breen has maintained a strong interest in her research. She continues to conduct research on antiphospholipid syndrome and thrombosis. Presently, she is involved in several current clinical trials and translational research. Dr Breen has had her work published in various peer-reviewed journals. On a regular basis, Dr Breen lectures both nationally and internationally.

View Profile

Overall assessment of their patients


  • Related procedures
  • Thrombosis
    Growth factors
    Bone marrow cancers
    Pancreatic cancer
    Pulmonary embolism
    Immunotherapy
    Anaemia
    Alteration of red blood cells
    Multiple myeloma
    Myelodysplastic syndrome
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.